tiprankstipranks
Advertisement
Advertisement

KP Tissue Reports Strong 2025 Results and Plans New U.S. Tissue Facility

Story Highlights
  • Kruger Products, partly owned by KP Tissue, posted solid 2025 growth with higher revenue, profitability and margins.
  • Strong fourth‑quarter results, U.S. expansion plans and a new western TAD plant reinforce Kruger Products’ growth trajectory.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
KP Tissue Reports Strong 2025 Results and Plans New U.S. Tissue Facility

Claim 55% Off TipRanks

KP Tissue ( (TSE:KPT) ) has issued an update.

KP Tissue reported that affiliate Kruger Products delivered strong financial and operational results in 2025, with full‑year revenue rising 7.5% to $2.20 billion and Adjusted EBITDA up 20.2% to $318.2 million. Net income more than tripled to $75.5 million, reflecting margin gains driven by higher volumes, lower pulp and freight costs, and productivity improvements, and the company declared a $0.18 per‑share dividend.

Fourth‑quarter performance underscored the momentum, as revenue grew 3.8% to $560.1 million and Adjusted EBITDA jumped 26% to $84.2 million, supported by increased in‑sourcing from the Sherbrooke Expansion Project that boosted away‑from‑home margins. Management highlighted diversified growth across Canada and the U.S., outlined plans for a new through‑air‑dried tissue facility in the western United States targeted for 2028, and guided that first‑quarter 2026 Adjusted EBITDA should be in line with the strong fourth‑quarter level.

The most recent analyst rating on (TSE:KPT) stock is a Hold with a C$11.00 price target. To see the full list of analyst forecasts on KP Tissue stock, see the TSE:KPT Stock Forecast page.

Spark’s Take on TSE:KPT Stock

According to Spark, TipRanks’ AI Analyst, TSE:KPT is a Neutral.

The score is primarily held back by inconsistent profitability and uneven/unclear latest cash flow in the provided statements, despite a strong low-leverage balance sheet. Offsetting this, technicals show a clear uptrend with positive momentum, and the earnings call indicated strong recent operating performance and credible long-term capacity expansion plans. Valuation is mixed, with a high dividend yield but a relatively high P/E.

To see Spark’s full report on TSE:KPT stock, click here.

More about KP Tissue

KP Tissue Inc. holds a 12.1% stake in Kruger Products Inc., Canada’s leading manufacturer of consumer and away‑from‑home tissue products. Kruger Products markets well‑known brands such as Cashmere, Purex, SpongeTowels, Scotties, White Swan and Bonterra in Canada, while expanding its U.S. presence with the White Cloud brand and premium private‑label offerings.

Average Trading Volume: 14,050

Technical Sentiment Signal: Buy

Current Market Cap: C$105.6M

For a thorough assessment of KPT stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1